Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q73739741)
Watch
English
Implications of pathogenetic and prognostic features for management of myelodysplastic syndromes
scientific article published on 01 April 2001
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
title
Implications of pathogenetic and prognostic features for management of myelodysplastic syndromes
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
author name string
P Greenberg
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
language of work or name
English
0 references
publication date
1 April 2001
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
volume
357
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
issue
9262
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
page(s)
1059-1060
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
cites work
Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904306-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904306-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904306-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904306-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904306-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of the multidrug resistance-associated protein in myelodysplastic syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904306-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904306-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(00)04306-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
PubMed publication ID
11297953
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11297953
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11297953%20AND%20SRC:MED&resulttype=core&format=json
retrieved
6 November 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
